Halozyme Therapeutics Inc. Common Stock vs Navitas Semiconductor Corporation Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Navitas Semiconductor Corporation Common Stock trades at $10.78 (market cap $2.87B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 4.4× Navitas Semiconductor Corporation Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Navitas Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Navitas Semiconductor Corporation Common Stock for 0 Days on average.
| HALO | NVTS | |
|---|---|---|
Market Cap | $12.58B | $2.87B |
Volume | 2,179,278 | 13,752,519 |
Sector | Health | Technology |
52-Week High | $115.22 | $31.79 |
52-Week Low | $61.63 | $7.14 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $2.32B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Navitas Semiconductor designs and markets gallium nitride and silicon carbide power semiconductors. Its products are used in power conversion and charging for data centers, energy infrastructure, and industrial applications.
Read more on NVTS →